Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CSBR

Champions Oncology (CSBR) Stock Price, News & Analysis

Champions Oncology logo

About Champions Oncology Stock (NASDAQ:CSBR)

Advanced Chart

Key Stats

Today's Range
$9.00
$9.72
50-Day Range
$9.11
$10.96
52-Week Range
$3.60
$11.99
Volume
32,633 shs
Average Volume
40,472 shs
Market Capitalization
$89.10 million
P/E Ratio
19.23
Dividend Yield
N/A
Price Target
$12.00
Consensus Rating
Buy

Company Overview

Champions Oncology Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
77th Percentile Overall Score

CSBR MarketRank™: 

Champions Oncology scored higher than 77% of companies evaluated by MarketBeat, and ranked 214th out of 923 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Champions Oncology has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Champions Oncology has received no research coverage in the past 90 days.

  • Read more about Champions Oncology's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Champions Oncology is 19.23, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 27.93.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Champions Oncology is 19.23, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 30.04.

  • Price to Book Value per Share Ratio

    Champions Oncology has a P/B Ratio of 23.95. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    1.77% of the float of Champions Oncology has been sold short.
  • Short Interest Ratio / Days to Cover

    Champions Oncology has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Champions Oncology has recently decreased by 1.01%, indicating that investor sentiment is improving.
  • Dividend Yield

    Champions Oncology does not currently pay a dividend.

  • Dividend Growth

    Champions Oncology does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.77% of the float of Champions Oncology has been sold short.
  • Short Interest Ratio / Days to Cover

    Champions Oncology has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Champions Oncology has recently decreased by 1.01%, indicating that investor sentiment is improving.
    • Insider Buying vs. Insider Selling

      In the past three months, Champions Oncology insiders have not sold or bought any company stock.

    • Percentage Held by Insiders

      46.98% of the stock of Champions Oncology is held by insiders. A high percentage of insider ownership can be a sign of company health.

    • Percentage Held by Institutions

      41.30% of the stock of Champions Oncology is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

    • Read more about Champions Oncology's insider trading history.
    Receive CSBR Stock News and Ratings via Email

    Sign-up to receive the latest news and ratings for Champions Oncology and its competitors with MarketBeat's FREE daily newsletter.

    CSBR Stock News Headlines

    Trump set to Boost Social Security Checks by 400%?
    If you're collecting or planning to collect social security... You should see this presentation about President Trump's Executive Order #14196. Legendary investor Louis Navellier believes it could soon not only save Social Security from collapse... But BOOST benefits for millions of retirees by up to 400%. No wonder the financial times called this new initiative...
    See More Headlines

    CSBR Stock Analysis - Frequently Asked Questions

    Champions Oncology, Inc. (NASDAQ:CSBR) released its earnings results on Wednesday, July, 23rd. The biotechnology company reported ($0.13) earnings per share (EPS) for the quarter. The biotechnology company had revenue of $12.35 million for the quarter. Champions Oncology had a trailing twelve-month return on equity of 196.12% and a net margin of 8.26%.
    Read the conference call transcript
    .

    Based on aggregate information from My MarketBeat watchlists, some other companies that Champions Oncology investors own include Intel (INTC), Gilead Sciences (GILD), Micron Technology (MU), NVIDIA (NVDA), AT&T (T), Advanced Micro Devices (AMD) and Bristol Myers Squibb (BMY).

    Company Calendar

    Last Earnings
    7/23/2025
    Today
    8/08/2025
    Fiscal Year End
    4/30/2026

    Industry, Sector and Symbol

    Stock Exchange
    NASDAQ
    Sector
    Medical
    Industry
    MED - DRUGS
    Sub-Industry
    N/A
    Current Symbol
    NASDAQ:CSBR
    CIK
    771856
    Employees
    143
    Year Founded
    N/A

    Price Target and Rating

    High Price Target
    $12.00
    Low Price Target
    $12.00
    Potential Upside/Downside
    +90.2%
    Consensus Rating
    Buy
    Rating Score (0-4)
    3.00
    Research Coverage
    1 Analysts

    Profitability

    EPS (Trailing Twelve Months)
    ($0.06)
    Trailing P/E Ratio
    19.23
    Forward P/E Ratio
    N/A
    P/E Growth
    N/A
    Net Income
    $4.70 million
    Net Margins
    8.26%
    Pretax Margin
    8.12%
    Return on Equity
    196.12%
    Return on Assets
    16.62%

    Debt

    Debt-to-Equity Ratio
    N/A
    Current Ratio
    0.94
    Quick Ratio
    0.94

    Sales & Book Value

    Annual Sales
    $56.94 million
    Price / Sales
    1.53
    Cash Flow
    $0.44 per share
    Price / Cash Flow
    14.28
    Book Value
    $0.27 per share
    Price / Book
    23.37

    Miscellaneous

    Outstanding Shares
    13,780,000
    Free Float
    7,305,000
    Market Cap
    $86.95 million
    Optionable
    Optionable
    Beta
    0.46

    Social Links

     The Best Nuclear Energy Stocks to Buy Cover

    Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

    Get This Free Report

    This page (NASDAQ:CSBR) was last updated on 8/8/2025 by MarketBeat.com Staff
    From Our Partners